British HealthTech Startup Punto Health Gets €100k Grant For Their Dementia Care App

This support comes as a result of Punto Health winning the second edition of the NN Social Innovation Startup Award at The Next Web Conference.

“One in two people will be affected by dementia during their lifetime, and women are disproportionately impacted, both as patients and as carers,” says Anna Muñoz Farré, Co-founder and CEO of Punto Health. “This €100k grant from NN Group, combined with Rubio’s network and expertise in scaling impact startups, gives us everything we need to transform dementia care and help families better manage the rising burden globally.”

The startup aims to become a trusted companion for those affected by cognitive diseases. Backed by deep healthcare experience and advanced technology, Punto Health develops and tests its solutions in close collaboration with patients, caregivers, and clinicians every step of the way.

Read Also - Nvelop Funding News- Finnish Startup Nvelop Secures €1.2 Million In Seed Round

“We designed this award to champion early-stage social enterprises that provide innovative solutions for improving financial, physical and mental well-being. Developing products and services that create solutions for people at scale, is still a challenge for many social entrepreneurs to make the impact that they envision. The diversity of solutions this year shows that technology can truly be a force for good,” says Lonneke Roza, Head of Community Investment at NN Group. “From AI transforming dementia care to platforms redirecting digital talent toward cybersecurity – these are the innovations that make a difference for people who need it most.”

Farré was inspired to start Punto Health after her grandfather’s dementia diagnosis exposed significant gaps in the healthcare system. With an estimated 78 million people projected to be diagnosed with dementia by 2030, she and Eckersley set out to change the landscape of care.

Their goal is to use AI to deliver personalised support that empowers patients, families, and healthcare providers—shifting dementia care toward a more proactive, compassionate, and informed approach.

Ilonka Jankovich, Venture Partner at Rubio Impact Ventures, adds: “Some of the most impactful startups are built by people with deep personal insight into the problems they’re solving. But turning that into a scalable business – especially in sectors like mental health, healthcare access, or financial resilience – is incredibly hard without the right kind of support. This award was created to fill that gap. Not just with funding, but with the guidance from NN Group and Rubio and the support of the community of innovators we’ve created with this competition. Each and every one is committed to changing the system, so that tech-driven solutions for well-being become the norm, not the exception.”

Punto Health currently offers two main products. The first is PuntoCare, a smartphone and tablet app designed to support people with cognitive impairments and their families. It provides personalised daily care plans, cognitive exercises, physical activity suggestions, healthy habit guidance, relaxation techniques, and expert-curated articles with clinically validated information.

The app also includes an AI assistant that interacts with users, offering tips, strategies, and answers to common questions, along with a symptom diary to help track and manage changes over time.

The second product is PuntoClinic, a speech-based digital biomarker tool that enables cognitive assessments. It helps improve remote monitoring of disease progression and supports early detection of cognitive decline.

About Punto Health

Founded in 2023 by Anna Muñoz Farré and Jack Eckersley, Punto Health is on a mission to show how AI can shift dementia care from crisis response to proactive, personalised family support.